-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, B+Rf2EsxEtZUtY9wZW23I6BAi4ZqyjQzL1RMFy070bHaQAIEWSqFGAtS4ws1HJIB HAbAcWYaO4ssm49FaYEpJg== 0001209191-07-006147.txt : 20070130 0001209191-07-006147.hdr.sgml : 20070130 20070130194805 ACCESSION NUMBER: 0001209191-07-006147 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070126 FILED AS OF DATE: 20070130 DATE AS OF CHANGE: 20070130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solexa, Inc. CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: LYNX THERAPEUTICS INC DATE OF NAME CHANGE: 19931008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WHITTERS JOSEPH E CENTRAL INDEX KEY: 0001186680 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 07565974 BUSINESS ADDRESS: STREET 1: C/O FIRST HEALTH GROUP CORP STREET 2: 3200 HIGHLAND AVE. CITY: DOWNERS GROVE STATE: IL ZIP: 60515 4 1 bsf26824_bsf1jw.xml MAIN DOCUMENT DESCRIPTION X0202 4 2007-01-26 1 0000913275 Solexa, Inc. SLXA 0001186680 WHITTERS JOSEPH E C/O SOLEXA, INC. 25861 INDUSTRIAL BLVD. HAYWARD CA 94545 1 0 0 0 Stock Option (Right to Buy) 9.06 2007-01-26 4 D 0 20000 0.00 D 2016-10-03 Common Stock 20000 0 D Stock Option (Right to Buy) 9.06 2007-01-26 4 D 0 1836 0.00 D 2016-10-03 Common Stock 1836 0 D This option, which provided for vesting monthly and ratably over the 12 month period beginning on July 28, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 6,880 shares at an exercise price of $26.34 per share. This option, which provided for vesting monthly and ratably over the 12 month period beginning on October 4, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 631 shares at an exercise price of $26.34 per share. /s/ Joseph E. Whitters, by Kathy San Roman, attorney-in-fact 2007-01-29 -----END PRIVACY-ENHANCED MESSAGE-----